Table 1 Baseline characteristics of HD patients with serum Zn below and above median value
From: Serum zinc values, ankle brachial index and mortality in hemodialysis patients
Parameter | Serum zinc below median value (n = 30)* | Serum zinc above median value (n = 31)# | p value |
|---|---|---|---|
Age (years) | 63.3 ± 15.8 | 59.7 ± 11.0 | 0.311 |
Male gender (n) | 53.3% (16) | 54.8% (17) | 0.695 |
Body Mass Index (BMI; kg/m2) | 26.8 ± 5.2 | 25.0 ± 5.2 | 0.183 |
Ankle-brachial index (ABI) | 1.2 ± 1.4 | 1.1 ± 1.0 | 0.036 |
Arterial hypertension (n) | 90% (27) | 74.3% (23) | 0.111 |
Diabetes mellitus (n) | 30% (9) | 19.4% (6) | 0.338 |
Smoking (n) | 30% (9) | 41.9% (13) | 0.336 |
C-reactive protein – CRP (mg/L) | 11.4 ± 19.7 | 5.7 ± 6.0 | 0.130 |
Serum albumin (g/L) | 37.3 ± 5.2 | 40.5 ± 3.2 | 0.005 |
Serum phosphate (mmol/L) | 1.4 ± 0.5 | 1.6 ± 0.5 | 0.097 |
Total cholesterol (mmol/L) | 3.8 ± 0.8 | 4.3 ± 1.1 | 0.055 |
Triglycerides (mmol/L) | 1.7 ± 0.7 | 1.7 ± 1.4 | 0.768 |
Oral nutritional supplement (n/%) | 12/40 | 14/45.2 | 0.686 |